Increased lipoxin B4 levels in children with atopic dermatitis
Background Atopic dermatitis (AD) is the most common chronic inflammatory skin disease in the pediatric population. The pathophysiology of AD is complex and not clearly understood. The role of lipoxin B4 (LXB4), an anti-inflammatory mediator, has not been sufficiently investigated in children with A...
Saved in:
Main Authors: | Himmet Haluk Akar (Author), Mikdat Yildiz (Author) |
---|---|
Format: | Book |
Published: |
Indonesian Pediatric Society Publishing House,
2019-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lipoxin A4 Ameliorates Imiquimod-Induced Psoriasis-Like Dermatitis via Promoting the Regression of Inflammation
by: Hu F, et al.
Published: (2023) -
Increasing of Urinary 8-Hydroxydeoxyguanosine (8-OHdG) Levels in Children with Atopic Dermatitis
by: Shakti Indraprasta, et al.
Published: (2017) -
Susbstance P Levels in Children with Atopic Dermatitis
by: Khairina Nasution, et al.
Published: (2021) -
Zinc levels and features of atopic dermatitis in children
by: T.V. Sorokman, et al.
Published: (2020) -
DOCK8 deficiency in a boy who presented with a giant aortic aneurysm between aortic root and iliac bifurcation
by: Türkan Patıroğlu, et al.
Published: (2016)